Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions
Must Reads by Date
Must reads for theWeek ending January 31, 2016
Two New Indications for Cosentyx , FDA approval to treat ankylosing spondylitis, PsA
Expanded Approval for Opdivo-Yervoy Combination, Indicated for BRAF V600 mutation-positive melanoma
Recurring Melanoma in Women , Vigilance suggested in this specific subgroup
Etanercept Evaluated in Youths with Psoriasis , Up to half stayed clear/almost clear after 5 years
Shiny White Blotches and Strands Predict BCC , Sensitivity and specificity analyzed
Must reads for theWeek ending January 24, 2016
An Unrecognized Risk Factor for Zoster , Case control study shows asthma’s impact
Must reads for theWeek ending January 10, 2016
OTC Botanical’s Value in Acne Treatment , Compared with benzoyl peroxide in 12-week trial
Must reads for theWeek ending December 27, 2015
Inflamed Frozen Sections from Mohs Surgery , Predictive value of adjacent tumor evaluated
Atopic Dermatitis and Anemia in Children, Analysis of >237,000 young people examines link
Thigh Treatments Using Radiofrequency Device , Safety and circumferential reduction assessed
Predicting Food Allergy in Infants with Dermatitis, Role of food-specific immunoglobulin E measurements
Ipilimumab in Patients With Advanced Melanoma , Managing adverse events tied to autoimmune disease
Must reads for theWeek ending December 20, 2015
Efficacy of Anakinra in Severe HS, Study also looks at safety measures
Is Ustekinumab an Effective Treatment for HS? , Study also searched for biomarker
Ertapenem & Antibiotic Consolidation Treatments, Rating effectiveness in severe HS